Ardent Health, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 |
|---|---|---|---|---|
| Revenue | $6.3B | $6.0B | $5.4B | $5.1B |
| Cash from operations | $470.5M | $315.0M | $221.7M | -$38.4M |
| Capital expenditure | $16.4M | $9.3M | $16.4M | $9.7M |
| Free cash flow | $454.1M | $305.8M | $205.3M | -$48.1M |
| Share repurchases | $3.2M | — | — | — |
| Impairments | — | $0 | $0 | $0 |
| Total assets | $5.3B | $5.0B | $4.7B | — |
| Total liabilities | $3.6B | $3.4B | $3.6B | — |
| Total debt | $1.1B | $1.1B | $1.2B | — |
Shares outstanding 143.4M · Free float 22.9%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.